Table E1.
Q1. Does your Pediatric Asthma clinic continue to run physically? |
Yes |
No |
Q2. Has the number of evaluated cases changed in the last month? |
Increased |
Stable |
Decreased |
Q3. Has the planned monitoring frequency of patients changed? |
No |
More frequently |
Less frequently |
Currently unstable/unknown |
Q4. Do you offer a virtual (online or telephone) clinic/consultation? |
Yes |
No |
Q5. In the last few weeks, has the number of evaluated cases |
Increased? |
Remain stable? |
Decreased? |
Q6. Approximately how many patients do you see per week (number)? |
Number: _______ |
Q7. Has the type/severity/priority of patients changed? |
No |
Yes—more severe |
Yes—patients receiving biologicals only |
Yes—other priority please specify |
Q8. Which of the following methods do you use to monitor your patients? |
A standardized questionnaire |
An asthma control test (ACT, ACQ, other) |
Peak flow meter reading |
Portable spirometer reading |
Adherence evaluation |
Diary cards |
Symptom-recording app/telemedicine platform |
Other (please specify) |
Q9. What has been your experience with your virtual clinic so far? |
As good as the face-to-face clinic |
Somehow compromised but still okay |
Only viable for a short period of time |
Unsatisfactory—low-quality medical service |
Other (please specify): _______ |
Q10. Do you offer a helpline for your pediatric asthma patients? |
Yes |
No |
Q11. If you do not offer physical or virtual clinic, please describe expectations/plans around pediatric asthma patients in the near future. |
Free text: __________ |
Q12. Do you actively send advice to your asthma patients? |
No |
By email |
Through social media |
Through website |
Q13. In the last few weeks have you received any new patients? |
No |
Yes—a few |
Yes—several |
Q14. If yes, how many new patients do you receive every week, during the COVID-19 pandemic? |
Number: _____ |
Q15. In your asthma clinic, do you have any patients receiving biologicals? |
Yes |
No |
Q16. If yes, how many? |
Number: _____ |
Q17. Do they continue their regular dosage? |
Yes |
No—stopped |
No—reduced frequency |
Q18. Has any of your pediatric asthma patients had confirmed COVID? |
No |
Yes |
Q19. If yes, approximately how many? |
Number: _____ |
Q20. Their symptoms at presentation included: |
Runny/blocked nose. Percentage: _____ |
Cough. Percentage: _____ |
Wheeze. Percentage: _____ |
Shortness of breath. Percentage: _____ |
Fever. Percentage: _____ |
Nonrespiratory symptoms/other. Percentage: _____ |
Q21. Their clinical course in regard to their asthma has been: |
Mild. Percentage: _____ |
Moderate (treated at home). Percentage: _____ |
Severe exacerbation (emergency visit or hospital admission). Percentage: _____ |
Required ICU admission or intubation. Percentage: _____ |
Death. Percentage: _____ |
Q22. Has any of your pediatric asthma patients had suspected, but not confirmed COVID? |
No |
Yes |
Q23. If yes, approximately how many? |
Number: _____ |
Q24. Their symptoms at presentation included: |
Runny/blocked nose. Percentage: _____ |
Cough. Percentage: _____ |
Wheeze. Percentage: _____ |
Shortness of breath. Percentage: _____ |
Fever. Percentage: _____ |
Nonrespiratory symptoms/other. Percentage: _____ |
Q25. Their clinical course in regard to their asthma has been: |
Mild. Percentage: _____ |
Moderate (treated at home). Percentage: _____ |
Severe exacerbation (emergency visit or hospital admission). Percentage: _____ |
Required ICU admission or intubation. Percentage: _____ |
Death. Percentage: _____ |
Q26. In the last month, approximately how many patients have you monitored (either physically or virtually)? |
Number: _____ |
Q27. From the patients you have monitored, what is the proportion with |
Well-controlled asthma. Percentage: _____ |
Partially controlled asthma. Percentage: _____ |
Uncontrolled asthma. Percentage: _____ |
Q28. How does this compare with your expectations for the same patients? |
As expected. Percentage: _____ |
Better that expected. Percentage: _____ |
Worse than expected. Percentage: _____ |
Q29. What was the proportion of patients with regard to treatment changes? |
Increased treatment. Percentage: _____ |
Continued treatment. Percentage: _____ |
Decreased treatment. Percentage: _____ |
Q30. Is availability or access to medication an issue? |
Yes |
No |
Q31. Have you observed changes in adherence to controller medications? |
No changes in adherence. Percentage: _____ |
Increased adherence. Percentage: _____ |
Reduced adherence. Percentage: _____ |
Any comment on adherence changes? _____ |
Q32. Number of your patients (approximately) who have suffered an exacerbation during the last month and treated at outpatients (independent of COVID)? |
Number: _____ |
Q33. Number of your patients (approximately) who have suffered an exacerbation during the last month and were hospitalized (independent of COVID)? |
Number: _____ |
Q34. In which country do you practice? |
Q35. In what setting do you practice? |
Tertiary/university hospital |
Secondary hospital |
Primary care |
Community center |
Q36. Your email (optional) |
Q37. Your name (optional) |
ACQ, Asthma Control Questionnaire; ACT, Asthma Control Test; ICU, intensive care unit.